Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boehringer Ingelheim's Humira Biosimilar Under Review by EMA, FDA
Boehringer Ingelheim's Humira Biosimilar Under Review by EMA, FDA
Boehringer Ingelheim's Humira Biosimilar Under Review by EMA, FDA
Submitted by
admin
on January 20, 2017 - 9:45am
Source:
Yahoo/GuruFocus
News Tags:
Boehringer Ingelheim
Humira
biosimilars
FDA
EMA
BI 695501
AbbVie
Headline:
Boehringer Ingelheim's Humira Biosimilar Under Review by EMA, FDA
Do Not Allow Advertisers to Use My Personal information
